| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0083 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |